Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
VYNE Therapeutics Inc. (VYNE) had Return on Equity of -19.49% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.20M |
|
$-8.61M |
|
-- |
|
$0.20M |
|
$9.40M |
|
$-9.20M |
|
$0.59M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-8.60M |
|
$-8.61M |
|
$-8.60M |
|
$-9.20M |
|
$-9.52M |
|
42.67M |
|
42.67M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$54.91M |
|
$0.11M |
|
$1.51M |
|
$56.42M |
|
$12.29M |
|
-- |
|
-- |
|
$12.29M |
|
$44.13M |
|
$44.13M |
|
$44.13M |
|
15.96M |
|
| Cash Flow Statement Financials | |
$-11.46M |
|
$19.83M |
|
$-0.09M |
|
$19.93M |
|
$28.21M |
|
$8.28M |
|
$0.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4552.97% |
|
-4552.97% |
|
-- |
|
-4258.91% |
|
-4262.87% |
|
$-11.46M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-19.49% |
-19.49% |
|
-15.25% |
|
-19.49% |
|
$2.77 |
|
$-0.27 |
|
$-0.27 |
|